Results 251 to 260 of about 703,542 (394)

Influence of Obesity Class on Clinical Outcomes in Alcoholic Hepatitis: A National Cohort Study of Mortality, Complications, and Resource Use. [PDF]

JGH Open
Jaan A, Najim MS, Farooq U, Dhawan A, Nawaz H, Jahagirdar V, Ali H, Ahlawat S.   +7 more
europepmc   +1 more source

Shc Is Implicated in Calreticulin-Mediated Sterile Inflammation in Alcoholic Hepatitis. [PDF]

Cell Mol Gastroenterol Hepatol, 2023
Li Y, Jiang JX, Fan W, Fish SR, Das S, Gupta P, Mozes G, Vancza L, Sarkar S, Kunimoto K, Chen D, Park H, Clemens D, Tomilov A, Cortopassi G, Török NJ.   +15 more
europepmc   +1 more source

Autophagy in liver diseases: A matter of what to remove and whether to keep [PDF]

, 2018
Yin, Xiao-Ming
core   +1 more source

Hypoxia‐Enhanced Wharton's Jelly Mesenchymal Stem Cell Therapy for Liver Fibrosis: A Comparative Study in a Rat Model

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Liver fibrosis is a progressive disease that can lead to cirrhosis and liver failure, with limited treatment options. Wharton's jelly‐derived MSCs (WJ‐MSCs) have immunomodulatory and antifibrotic potential. Hypoxia preconditioning enhances MSC survival and paracrine activity, but its effects in liver fibrosis remain unclear.
Wei‐Ting Kuo, Chen‐Yuan Hsiao, Sheng‐Hao Chiu, Shu‐Cheng Chou, Ching‐Shu Chiang, Jui‐Yu Chen, Solomon Chih‐Cheng Chen, Tien‐Hua Chen, Jia‐Fwu Shyu, Chi‐Hung Lin, Pei‐Jiun Tsai   +10 more
wiley   +1 more source

Targeted Plasma Bile Acid Metabolomic Analysis in Metabolic Dysfunction-Associated Steatohepatitis and Alcoholic Hepatitis. [PDF]

Biomedicines
Hirata Y, Sakuma Y, Ogiso H, Nagai R, Aizawa K.   +4 more
europepmc   +1 more source

Liver regeneration as treatment target for severe alcoholic hepatitis. [PDF]

World J Gastroenterol, 2022
Virovic-Jukic L, Ljubas D, Stojsavljevic-Shapeski S, Ljubičić N, Filipec Kanizaj T, Mikolasevic I, Grgurevic I.   +6 more
europepmc   +1 more source

Early change in bilirubin levels is an important prognostic factor in severe alcoholic hepatitis treated with prednisolone

, 2003
Philippe Mathurin, Marcelle Abdelnour, Marie-José Ramond, Nicolas Carbonell, Lætitia Fartoux, Lawrence Serfaty, Dominique Valla, Raoul Poupon, Jean‐Claude Chaput, Sylvie Naveau   +9 more
openalex   +1 more source

Neutrophil dysfunction in alcoholic hepatitis superimposed on cirrhosis is reversible and predicts the outcome [PDF]

, 2007
Rajeshwar P. Mookerjee, Vanessa Stadlbauer, Sukhwinderjit Lidder, Gavin Wright, Stephen Hodges, Nathan Davies, Rajiv Jalan   +6 more
openalex   +1 more source

A Point‐of‐Care Model for Hepatitis C Elimination in Remote Islands of Taiwan

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Timely and efficient diagnosis of hepatitis C virus (HCV) infection remains the effective approach for the subsequent care cascade of HCV treatment. It is of importance in under‐resourced areas. The study aimed to assess the feasibility of a point‐of‐care (POC) model by a rapid diagnostic test and subsequent confirmational HCV RNA test in ...
Tzu‐Chun Lin, Pei‐Chien Tsai, Chung‐Feng Huang, Ming‐Lun Yeh, Yu‐Ju Wei, Ming‐Yen Hsieh, Ming‐Jong Bair, Chia‐Yen Dai, Jee‐Fu Huang, Ming‐Lung Yu, Wan‐Long Chuang   +10 more
wiley   +1 more source

RASGRF2 as a potential pathogenic gene mediating the progression of alcoholic hepatitis to alcohol-related cirrhosis and hepatocellular carcinoma. [PDF]

Discov Oncol
Chen Z, Fan D, Hang T, Yue X.
europepmc   +1 more source